Nextage Therapeutics Ltd
Tel Aviv Stock Exchange NXTG.TA
Nextage Therapeutics Ltd Revenue for the year ending December 31, 2023: USD 241.26 K
Nextage Therapeutics Ltd Revenue is USD 241.26 K for the year ending December 31, 2023, a 0.00% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
-
Nextage Therapeutics Ltd Revenue for the year ending December 31, 2022 was USD 0.00, a -100.00% change year over year.
-
Nextage Therapeutics Ltd Revenue for the year ending December 31, 2021 was USD 29.29 K, a -50.70% change year over year.
-
Nextage Therapeutics Ltd Revenue for the year ending December 31, 2020 was USD 59.40 K, a -30.80% change year over year.
-
Nextage Therapeutics Ltd Revenue for the year ending December 31, 2019 was USD 85.84 K, a -16.09% change year over year.
Key data
| Date | Revenue | Gross Profit | Operating Income | EBIT |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: NXTG.TA
| CEO | Mr. Abraham Dreazen |
| IPO Date | Aug. 12, 2002 |
| Location | Israel |
| Headquarters | Einstein St. Building 13B |
| Employees | 42 |
| Sector | Health Care |
| Industries | |
Description
Nextage Therapeutics Ltd develops cannabinoid-based products. The company is based in Ness Ziona, Israel.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email